Your browser doesn't support javascript.
loading
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
Drake, Thomas M; Docherty, Annemarie B; Harrison, Ewen M; Quint, Jennifer K; Adamali, Huzaifa; Agnew, Sarah; Babu, Suresh; Barber, Christopher M; Barratt, Shaney; Bendstrup, Elisabeth; Bianchi, Stephen; Villegas, Diego Castillo; Chaudhuri, Nazia; Chua, Felix; Coker, Robina; Chang, William; Crawshaw, Anjali; Crowley, Louise E; Dosanjh, Davinder; Fiddler, Christine A; Forrest, Ian A; George, Peter M; Gibbons, Michael A; Groom, Katherine; Haney, Sarah; Hart, Simon P; Heiden, Emily; Henry, Michael; Ho, Ling-Pei; Hoyles, Rachel K; Hutchinson, John; Hurley, Killian; Jones, Mark; Jones, Steve; Kokosi, Maria; Kreuter, Michael; MacKay, Laura S; Mahendran, Siva; Margaritopoulos, George; Molina-Molina, Maria; Molyneaux, Philip L; O'Brien, Aiden; O'Reilly, Katherine; Packham, Alice; Parfrey, Helen; Poletti, Venerino; Porter, Joanna C; Renzoni, Elisabetta; Rivera-Ortega, Pilar; Russell, Anne-Marie.
Afiliação
  • Drake TM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Docherty AB; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Harrison EM; Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Quint JK; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Adamali H; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust and.
  • Agnew S; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom.
  • Babu S; Liverpool Interstitial Lung Disease Service, Aintree site, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
  • Barber CM; Queen Alexandra Hospital, Portsmouth, United Kingdom.
  • Barratt S; Northern General Hospital, Sheffield, United Kingdom.
  • Bendstrup E; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust and.
  • Bianchi S; Academic Respiratory Unit, University of Bristol, Southmead Hospital, Bristol, United Kingdom.
  • Villegas DC; Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
  • Chaudhuri N; Northern General Hospital, Sheffield, United Kingdom.
  • Chua F; Interstitial Lung Disease (ILD) Unit, Respiratory Medicine Department, Hospital of the Holy Cross and Saint Paul, Barcelona, Spain.
  • Coker R; ILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
  • Chang W; University of Manchester, Manchester, United Kingdom.
  • Crawshaw A; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • Crowley LE; Respiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Dosanjh D; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
  • Fiddler CA; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Forrest IA; University of Birmingham, Birmingham, United Kingdom.
  • George PM; Birmingham Interstitial Lung Disease Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Gibbons MA; Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
  • Groom K; Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • Haney S; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Hart SP; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • Heiden E; South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Exeter, United Kingdom.
  • Henry M; Respiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Ho LP; Northumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
  • Hoyles RK; Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom.
  • Hutchinson J; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Hurley K; Cork University Hospital, Cork, Ireland.
  • Jones M; Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Jones S; Oxford Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Kokosi M; King's Mill Hospital, Nottinghamshire, United Kingdom.
  • Kreuter M; Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • MacKay LS; Beaumont Hospital, Dublin, Ireland.
  • Mahendran S; University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Margaritopoulos G; National Institute for Health Research (NIHR) Southampton Biomedical Research Centre & Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.
  • Molina-Molina M; Action for Pulmonary Fibrosis, Stuart House, Peterborough, United Kingdom.
  • Molyneaux PL; Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
  • O'Brien A; Guys and St. Thomas' NHS Trust, London, United Kingdom.
  • O'Reilly K; Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Center for Lung Research, Heidelberg, Germany.
  • Packham A; Northumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
  • Parfrey H; Kingston Hospital NHS Foundation Trust, Surrey, United Kingdom.
  • Poletti V; ILD Unit, Manchester University Hospital NHS Foundation Trust, Wythenshawe Hospital, Wythenshawe, United Kingdom.
  • Porter JC; ILD Unit, Respiratory Department, University Hospital of Bellvitge, Institut d'Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Renzoni E; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Rivera-Ortega P; University Hospital Limerick, Limerick, Ireland.
  • Russell AM; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Am J Respir Crit Care Med ; 202(12): 1656-1665, 2020 12 15.
Article em En | MEDLINE | ID: mdl-33007173
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / COVID-19 / Hospitalização Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / COVID-19 / Hospitalização Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article